Clinical Trial Update: Efficacy of Zolmitriptan (Zomig) in the Treatment of Migraines in Adolescents [Phase 3]

View source ↗

Summary

Phase 3 trial results assess the efficacy of Zolmitriptan (Zomig) for treating migraines in adolescents; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Zomig (Zolmitriptan)

Snippet

Sponsor: Impax Laboratories, LLC | Conditions: Migraine | Phase 3 | Status: COMPLETED